Mineralys Therapeutics (MLYS) Research & Development (2022 - 2026)
Quarterly results put Research & Development at $24.4 million for Q1 2026, down 35.68% from a year ago — trailing twelve months through Mar 2026 was $118.5 million (down 32.56% YoY), and the annual figure for FY2025 was $132.0 million, down 21.69%.
Mineralys Therapeutics has reported Research & Development over the past 5 years, most recently at $24.4 million for Q1 2026.
- Research & Development reached $24.4 million in Q1 2026 per MLYS's latest filing, roughly flat from $24.4 million in the prior quarter.
- Across five years, Research & Development topped out at $54.0 million in Q3 2024 and bottomed at $5.6 million in Q2 2022.
- Median Research & Development over the past 5 years was $24.4 million (2026), compared with a mean of $24.8 million.
- The largest annual shift saw Research & Development soared 271.33% in 2023 before it plummeted 45.25% in 2025.
- Over 5 years, Research & Development stood at $7.8 million in 2022, then surged by 202.95% to $23.7 million in 2023, then surged by 88.17% to $44.6 million in 2024, then tumbled by 45.25% to $24.4 million in 2025, then dropped by 0.15% to $24.4 million in 2026.
- Business Quant data shows Research & Development for MLYS at $24.4 million in Q1 2026, $24.4 million in Q4 2025, and $31.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 1.54 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -2.30 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - | 24.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.37 Mn |
| Dec 31, 2025 | 24.40 Mn |
| Sep 30, 2025 | 31.45 Mn |
| Jun 30, 2025 | 38.28 Mn |
| Mar 31, 2025 | 37.88 Mn |
| Dec 31, 2024 | 44.57 Mn |
| Sep 30, 2024 | 53.99 Mn |
| Jun 30, 2024 | 39.27 Mn |
| Mar 31, 2024 | 30.75 Mn |
| Dec 31, 2023 | 23.69 Mn |
| Sep 30, 2023 | 22.50 Mn |
| Jun 30, 2023 | 11.88 Mn |
| Mar 31, 2023 | 12.29 Mn |
| Dec 31, 2022 | 7.82 Mn |
| Sep 30, 2022 | 6.06 Mn |
| Jun 30, 2022 | 5.60 Mn |
| Mar 31, 2022 | 6.78 Mn |